Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety and Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin and Sulfonylurea or Metformin in T2 Diabetic Patients

Trial Profile

Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety and Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin and Sulfonylurea or Metformin in T2 Diabetic Patients

Discontinued
Phase of Trial: Phase II

Latest Information Update: 31 Oct 2015

At a glance

  • Drugs BGP 15 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors N-Gene Research Laboratories
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 31 Jul 2013 Planned end date changed from 1 Nov 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
    • 10 Jul 2013 This trial has been discontinued in Hungary and has an unknown status in Germany and the USA because this information has not been verified recently in the ClinicalTrials.gov record (last verified June 2011).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top